Clinical usefulness of functional and genetic assessment of antiplatelet agents

Conrad-Simpfendorfer2
Conrad Simpfendorfer.
2011-08-03

More articles by this author

Non-cardiac surgery and coronary DES

Ajay Kirtane 2011-08-04

Global adoption of the transradial approach. The end of myths

Pablo Vázquez 2011-08-04

Current role of lower limb revascularization surgery

Roberto Sánchez 2011-08-03

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Coil embolization of segmental arteries as a spinal cord protection strategy prior to complex endovascular repair of thoracoabdominal aorta

Spinal cord ischemia remains one of the most devastating complications in the repair of thoracoabdominal aneurysms, with incidences of up to 20–30% in extensive...

Mechanical thrombectomy versus anticoagulation in intermediate-risk pulmonary embolism: systematic review and meta-analysis

Intermediate-risk pulmonary embolism (PE) has anticoagulation as the standard treatment, while reperfusion strategies remain a matter of debate. In this context, mechanical thrombectomy has...

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...